Newsletter | February 3, 2026

02.03.26 -- STREAM Edition: Data Governance And Regulations For AI Use In GMP With Peter Baker

The Truth About End-To-End Manufacturing Automation

Webinar | Invetech

Discover how automation, modular design, and real-time analytics are transforming cell and gene therapy manufacturing to unlock scalable, cost-effective production without compromising quality.

Navigating The Complex Landscape Of Lentiviral Vector Quality Control

Webinar | MilliporeSigma

Explore the latest in lentiviral vector release testing, including biosafety, regulatory insights, tips to reduce material use, and quality control strategies to ensure patient safety and accelerate your path to clinic.

Expert Insights Into Overcoming Challenges In AAV Downstream

Webinar | Thermo Fisher Scientific Bioproduction

Gain insight into the complexities of AAV purification to learn how industry leaders tackle downstream challenges, optimize workflows, and drive innovation in scalable, efficient gene therapy manufacturing solutions.

 

Optimization-By-Design: A Critical Factor In Viral Vector Scale Up, Scale Down

Video | Andelyn Biosciences

Focusing on critical parameters such as cell culture conditions, viral vector yield, and downstream purification strategies, can drive the success of scale-up and scale-down models for AAV production.

Data Governance And Regulations For AI Use In GMP With Peter Baker

Video | Bioprocess Online

In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Peter Baker, former FDA investigator and president of Live Oak Quality Assurance, to discuss the use of AI in regulated manufacturing.

Compliance To Confidence: Annex 1 For Small-Batch, High-Value Production

Webinar | 3P innovation

Get strategies for meeting the updated GMP Annex 1 in small-batch aseptic filling. Learn about contamination control, quality management, and equipment design for high-value liquid and powder products.